Poster Session 1-23 AML: Molecular Targeted Therapy

[PS1-23-4] Using venetoclax in relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Yu-Wen Wang¹, Chien-Chin Lin^2,4, Feng-Ming Tien^2,3, Cheng-Hong Tsai^2,3, Yun-Chu Lin², Chien-Ting Lin^2,3, Chieh-Lung Cheng², Hsin-An Hou², Hwei-Feng Tien² (1.Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan, 2.Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, 3.Tai-Cheng Stem Cell Therapy Center, National Taiwan University, Taipei, Taiwan, 4.Departments of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan)